Overview

Osimertinib Study in Indian Patients

Status:
Completed
Trial end date:
2020-04-15
Target enrollment:
Participant gender:
Summary
This is a prospective, single-arm, multicenter, phase-IV study investigating the safety of osimertinib in Indian adult patients.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Osimertinib